|
|
||||||||
American Journal of Clinical Nutrition, Vol 65, 88-94, Copyright © 1997 by The American Society for Clinical Nutrition, Inc
ORIGINAL RESEARCH COMMUNICATIONS |
EM Baarends, AM Schols, WD van Marken Lichtenbelt and EF Wouters
Department of Pulmonology, University of Limburg, Maastricht, Netherlands. e.baarends@PUL.RuLimburg.NL
Tissue depletion often occurs in patients with chronic obstructive pulmonary disease (COPD), even in those that are weight-stable. Limited data are available, however, about changes in body water compartments in chronic wasting diseases such as COPD. The purpose of this study was to measure body composition in severe COPD patients with special attention to fat-free mass (FFM) depletion and the distribution of body water compartments. Total body water (TBW) and extracellular water (ECW) were measured by deuterium and sodium bromide dilution techniques, respectively, in 38 COPD patients (age: 65 +/- 9 y, forced expiratory volume in 1 s: 38 +/- 14% of predicted) in a stable clinical condition. FFM was calculated by assuming a hydration coefficient of 73%. Underweight patients [body mass index (BMI; in kg/m2) < or = 21] were characterized by a significantly lower percentage fat mass than normal-weight patients, but no significant difference was found in the ratio of ECW to intracellular water (ICW)(BMI < or = 21: 0.72 +/- 0.12, BMI > 21: 0.71 +/- 0.16; NS). When the study population was divided into depleted patients (FFM/height2 < or = 15 kg/m2) and nondepleted patients (FFM/height2 > 15 kg/m2), there was no significant difference in the percentage fat mass, but the ECW-ICW ratio was significantly higher in the depleted patients (0.78 +/- 0.16) than in the nondepleted patients (0.66 +/- 0.12, P < 0.05); this was most pronounced in women. In conclusion, it was found that COPD patients with extreme FFM wasting are characterized by an increased ECW-ICW ratio despite a relatively spared fat mass.
This article has been cited by other articles:
![]() |
M. Cazzola, W. MacNee, F. J. Martinez, K. F. Rabe, L. G. Franciosi, P. J. Barnes, V. Brusasco, P. S. Burge, P. M. A. Calverley, B. R. Celli, et al. Outcomes for COPD pharmacological trials: from lung function to biomarkers Eur. Respir. J., February 1, 2008; 31(2): 416 - 469. [Abstract] [Full Text] [PDF] |
||||
![]() |
A.G.N. Agusti, A. Noguera, J. Sauleda, E. Sala, J. Pons, and X. Busquets Systemic effects of chronic obstructive pulmonary disease Eur. Respir. J., February 1, 2003; 21(2): 347 - 360. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Ritz, the Investigators of the Source Study, of the Human Nutrition Research, and Centre-Auvergne Chronic Cellular Dehydration in the Aged Patient J. Gerontol. A Biol. Sci. Med. Sci., June 1, 2001; 56(6): M349 - M352. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. L. H. Schiffelers, E. E. Blaak, E. M. Baarends, M. A. Van Baak, W. H. M. Saris, E. F. M. Wouters, and A. M. W. J. Schols {beta}-Adrenoceptor-mediated thermogenesis and lipolysis in patients with chronic obstructive pulmonary disease Am J Physiol Endocrinol Metab, February 1, 2001; 280(2): E357 - E364. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. C. Duane and N. B. Javitt 27-Hydroxycholesterol: production rates in normal human subjects J. Lipid Res., July 1, 1999; 40(7): 1194 - 1199. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |